BHC:CC - Bausch Health raises 2025 revenue guidance to $5B-$5.1B while strengthening Solta and Salix growth
2025-10-29 20:27:27 ET
More on Bausch Health Companies
- Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript
- Bausch Health: Repricing Continues As Deleveraging Gains Traction
- Why Bausch Health Stock Surged By Nearly 20%
- Bausch Health rises on 2025 revenue, EBITDA guidance boost, Q3 beats
- Bausch Health Companies Q3 2025 Earnings Preview